COVID-19 vaccine targeting omicron 'not worth waiting for'

With COVID-19 cases now dropping in Massachusetts and at least 30 other states, Pfizer's new omicron-specific vaccine might end up never getting off the shelf.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting